ESR1 and breast carcinoma: Intriguingly, microRNAs (miRNAs), small non-coding RNAs of ∼24 nucleotides (nt) in length [7], have been recorded to exhibit aberrant expression patterns and participate in the pathogenesis and endocrine resistance of multiple ER-α-positive breast cancer [8], [9].